LAURA RECORD: Open Payments
NPI 1194965921 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 21 payments from 7 companies in 2025. Trend: 2023 $988 · 2024 $608 · 2025 $518
Food & beverage: $500Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $230 |
| Insmed, Inc. | 4 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| PFIZER INC. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
Products named: NUCALA, TRELEGY ELLIPTA, Arikayce, FASENRA, WINREVAIR, PAXLOVID, OPSYNVI, NUZYRA.
Industry payments across CA — which companies pay providers there.
